MedPath

Doubleblind randomized multicenter trial to investigate the influence of dimenhydrinate suppositories vs. placebo on oral rehydration in infants and children with infectious enteritis and vomiting - VomED

Phase 1
Conditions
Infectious enteritis with vomiting
MedDRA version: 8.1Level: PTClassification code 10058839Term: Enteritis infectious
Registration Number
EUCTR2005-003943-30-DE
Lead Sponsor
niversity of Leipzig
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
270
Inclusion Criteria

Acute vomiting started 8-24 hours prior the inclusion due to suggested infectious enteritis with at least 2 episodes of vomiting in the last 12 hours
age: 6 months - 5 years
weight over 7000g
outpatients
informed consent of at least one caregiver
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Contraindications against the study drug
receipts of the following medications:
Treatment with medicinal products with suspected interactions with dimenhydrinat,
Treatment with antiemetics or secretion inhibitors
severe disease with one of the following criteria:
bloody stool (with this disease)
suggested requirement of i.v. rehydration
Confirmed weight loss of more than 5% body weight
Metabolic acidosis (i.e. pH < 7,25) and/or electrolyte disturbances (measured by blood test in the emergency clinic originated in the responsibility of the investigator)
Suspected lack of cooperation and compliance by the patient or the caregiver(s) or linguistic problems of the parents
Participation in other medical trials

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath